Publications

Detection of NDM-1-producing Enterobacteriaceae in Romania: Report of the SENTRY Antimicrobial Surveillance Program. by Deshpande LM, Flonta M, Jones RN and Castanheira M published in J. Med. Microbiol. 2014; 63 (Pt 3): 483-484

Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel. by Castanheira M, Jones RN and Sader HS published in J. Chemother. 2014; 26 (4): 202-210

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-2011 in 14 European and Mediterranean countries. by Castanheira M, Deshpande LM, Costello A, Davies TA and Jones RN published in J. Antimicrob. Chemother. 2014; 69 (7): 1804-1814

Frequency of occurrence and antimicrobial susceptibility of gram-negative bacteremia isolates in patients with urinary tract infection: Results from United States and European hospitals (2009-2011). by Sader HS, Flamm RK and Jones RN published in J. Chemother. 2014; 26 (3): 133-138

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized with pneumonia in United States and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009-2012. by Sader HS, Farrell DJ, Flamm RK and Jones RN published in Int. J. Antimicrob. Agents. 2014; 43 (4): 328-334

Activity of oritavancin tested against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide. by Mendes RE, Sader HS, Flamm RK and Jones RN published in J. Antimicrob. Chemother. 2014; 69 (6): 1579-1581

Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program: Report of linezolid activity over 9 years (2004 – 2012). by Mendes RE, Hogan PA, Streit JM, Jones RN and Flamm RK published in J. Antimicrob. Chemother. 2014; 69 (6): 1582-1588

Post ß-lactamase inhibitor effect of tazobactam in combination with ceftolozane and tested against ESBL-producing strains. by Sader HS, Rhomberg PR and Jones RN published in Antimicrob. Agents Chemother. 2014; 58 (4): 2434-2437

Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011). by Pfaller MA, Flamm RK, Sader HS and Jones RN published in Diag. Microbiol. Infect. Dis 2014; 78 (4): 422-428

Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. by Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Florl C, Lockhart SR and Martin-Mazuelos published in Antimicrob. Agents Chemother. 2014; 58 (2): 916-922

Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States 2014. by Mendes RE, Flamm RK, Hogan PA, Ross JE and Jones RN published in Antimicrob. Agents Chemother. 2014; 58 (2): 1243-1247

Resistance surveillance program report for selected European nations (2011). by Jones RN, Flonta M, Gurler N, Cepparulo M, Mendes RE and Castanheira M published in Diagn. Microbiol. Infect. Dis. 2014; 78 (4): 429-436

Retrospective molecular analysis of DIM-1 metallo-ß-lactamase discovered in Pseudomonas stutzeri from India in 2000. by Deshpande LM, Jones RN, Woosley LN and Castanheira M published in Antimicrob. Agents Chemother. 2014; 58 (1): 596-598

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates. by Castanheira M, Woosley LN, Messer SA, Diekema DJ, Jones RN and Pfaller MA published in Antimicrob. Agents Chemother. 2014; 58 (1): 577-580

Contemporary diversity of ß-lactamases among Enterobacteriaceae in the nine United States census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent ß-lactamase groups. by Castanheira M, Farrell SE, Krause KM, Jones RN and Sader HS published in Antimicrob. Agents Chemother. 2014; 58 (2): 833-838

Activity of Echinocandins and Triazoles Against a Contemporary (2012) Worldwide Collection of Yeast and Moulds Collected from Invasive Infections, Lead author: Castanheira M/Pfaller M, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Ceftaroline Activity Tested against Bacterial Isolates from Pediatric Patients: Results from the Assessing Worldwide Antimicrobial Resistance and Evaluation (AWARE) Program for the United States (2011-2012), Lead author: Sader HS, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Emerging Resistant Serotype 19A Streptococcus pneumoniae in Adults in the US, Lead author: Isturiz RE, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Role of an Older Tetracycline for Treatment of Multidrug-resistant Acinetobacter spp. Infections: Understanding the Enhanced Potency of Minocycline!, Lead author: Jones RN, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Antimicrobial Activity of Ceftolozane/Tazobactam and Comparator Agents Tested Against Pseudomonas aeruginosa Isolates from United States Medical Centers (2011-2012), Lead author: Farrell DJ, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Activity of Ceftazidime-Avibactam Tested Against Enterobacteriaceae Isolates with Characterized &#223-Lactamase Encoding Genes Collected from United States Hospitals During 2012, Lead author: Castanheira M, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Ceftolozane/tazobactam Activity Tested against Aerobic Gram-negative Organisms Isolated from Intraabdominal Infections in European and United States Hospitals (2012), Lead author: Farrell DJ, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Frequency of Occurrence and Antimicrobial Susceptibility of Gram-negative Organisms Isolated from Healthcare Associated Urinary Tract Infections: Results from the Program to Assess Ceftolozane/Tazobactam Susceptibility (PACTS), Lead author: Farrell DJ, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Ceftazidime-avibactam Activity Tested Against Contemporary (2012) Gram-negative Organisms Causing Bloodstream Infections in United States (USA) Medical Centers, Lead author: Sader HS, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Activity of Ceftazidime-Avibactam Tested Against Contemporary (2012) Pathogens from Urinary Tract and Intraabdominal Infections from Patients in the USA, Lead author: Flamm R, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Linezolid Experience and Accurate Determination of Resistance (LEADER) Program for 2012: Regional Activity of Linezolid and Comparator Compounds, Lead author: Flamm R, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Evaluation of Daptomycin Activity Tested against 164,457 Bacterial Strains from Hospitalized Patients: Summary of 8 Years of Surveillance Program Worldwide (2005-2012), Lead author: Sader HS, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Antimicrobial Activity of Ceftaroline and Comparator Agents Tested Against Bacterial Isolates from Patients with Bacteremia in United States Medical Centers (2012), Lead author: Sader HS, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Antimicrobial Activity of Ceftaroline Tested against Contemporary (2012) Bacteria Isolated from Community-Acquired Respiratory Tract Infections, Including Oxacillin-resistant S. aureus, Lead author: Sader HS, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Antimicrobial Activity of Ceftaroline Tested against Multidrug Resistant (MDR) Streptococcus pneumoniae in the USA (2009-2012), Lead author: Flamm R, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Serotype distribution of Streptococcus pneumoniae recovered principally from non-sterile sites in patients aged =18 years in the US (2009-2011), Lead author: Hollingsworth RC, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Streptococcus pneumoniae serotype 3 recovered predominantly from non-sterile sites in patients aged =18 years in the USA (2009-2011), Lead author: Hewlett D, presented at ID Week, October 2 – 6, 2013, San Francisco, CA

Epidemiological Evidence for Glycopeptide Resistance Involvement in Persistence of Agr-defective Mutants among Methicillin-resistant Staphylococcus aureus (MRSA), Lead author: Shopsin, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Report of Linezolid Activity from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program 2012 (Europe, Latin America, Asia Pacific, Canada), Lead author: Flamm R, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Oritavancin activity against S. aureus Causing Invasive Infections in USA and European Hospitals: A Five-year International Surveillance Program, Lead author: Mendes RE, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Activity of Oritavancin Tested against Uncommonly Isolated Gram-positive Pathogens Responsible for Documented Infections in Hospitals Worldwide, Lead author: Mendes RE, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Activity of Ceftazidime-avibactam Tested against Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Gram-negative Pathogens from the Europe-Mediterranean Region, China and USA, Lead author: Flamm R, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Genotypic Characterization of Methicillin-resistant Staphylococcus aureus Strains Recovered from Pneumonia Clinical Trials for Ceftobiprole, Lead author: Mendes RE, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Interim use of Vancomycin Susceptibility Testing Results to Predict Activity of Oritavancin, a New Long Acting Lipoglycopeptide, Lead author: Jones RN, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Re-evaluating the Contemporary (2007-2011) Spectrums of Tetracyclines (Minocycline, Doxycycline, and Tetracycline) Tested against Enterobacteriaceae and Acinetobacter spp., Lead author: Jones RN, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

In Vitro Activity Of The Novel Pleuromutilin BC-3781 Tested against Bacterial Pathogens Causing Sexually Transmitted Diseases, Lead author: Paukner, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Activity Activity of Cadazolid against Gram-positive Clinical Isolates, Including Linezolid-resistant Subsets with Defined Resistance Mechanisms, Lead author: Mendes RE, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Activity of ß-lactam Agents Tested in Combination with Novel &#223-lactamase Inhibitor Compounds against Enterobacteriaceae Producing Extended-spectrum ß-lactamases, Lead author: Mendes RE, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Activity of the First-in-class Lpxc Inhibitor ACHN-975 and Comparators Tested against Gram-negative Organisms Including Isolates with Characterized Resistance Mechanisms, Lead author: Castanheira M, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Comparison of EUCAST and CLSI Broth Microdilution Methods for the Susceptibility Testing of 10 Systemically Active Antifungal Agents against Candida spp., Lead author: Castanheira M, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Intra- and Interlaboratory Study of Antifungal Susceptibility Testing of Isavuconazole against Aspergillus Strains, Lead author: Ghannoum, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Detection of fks Gene Hot Spot Mutations in Candida glabrata by CLSI Broth Microdilution Testing of Anidulafungin, Caspofungin and Micafungin using Epidemiological Cutoff Values, Lead author: Castanheira M, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Use of Micafungin as a Surrogate Marker to Predict Susceptibility and Resistance to Caspofungin among 3,747 Clinical Isolates of Candida using CLSI Methods and Interpretive Criteria, Lead author: Castanheira M, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

Activity of Isavuconazole and Comparator Antifungals Tested against Contemporary (2012) Fungal Clinical Isolates Collected Worldwide, Lead author: Castanheira M, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

MALDI-TOF MS Identification of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Program, Lead author: Woosley LN, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO